HER2 and proliferation of wound-induced breast carcinoma
dc.citation.epage | 1503 | en_US |
dc.citation.issueNumber | 9394 | en_US |
dc.citation.spage | 1503 | en_US |
dc.citation.volumeNumber | 362 | en_US |
dc.contributor.author | Tez, M. | en_US |
dc.contributor.author | Göçmen, E. | en_US |
dc.contributor.author | Özçelik, T. | en_US |
dc.date.accessioned | 2015-07-28T11:57:18Z | |
dc.date.available | 2015-07-28T11:57:18Z | |
dc.date.issued | 2003-11-01 | en_US |
dc.department | Department of Molecular Biology and Genetics | en_US |
dc.description.provenance | Made available in DSpace on 2015-07-28T11:57:18Z (GMT). No. of bitstreams: 1 10.1016-S0140-6736(03)14708-3.pdf: 54586 bytes, checksum: 9f32612afeb77bf377a022f11c83fe9f (MD5) | en |
dc.identifier.doi | 10.1016/S0140-6736(03)14707-1 | en_US |
dc.identifier.issn | 0140-6736 | |
dc.identifier.uri | http://hdl.handle.net/11693/11273 | |
dc.language.iso | English | en_US |
dc.publisher | The Lancet Publishing | en_US |
dc.relation.isversionof | http://dx.doi.org/10.1016/S0140-6736(03)14707-1 | en_US |
dc.source.title | The Lancet | en_US |
dc.subject | Angiopoietin | en_US |
dc.subject | Transforming growth factor beta | en_US |
dc.subject | Trastuzumab | en_US |
dc.subject | Vasculotropin | en_US |
dc.subject | Epidermal Growth Factor Receptor 2 | en_US |
dc.subject | Interstitial Collagenase | en_US |
dc.subject | Monoclonal Antibody | en_US |
dc.subject | Vasculotropin A | en_US |
dc.subject | Angiogenesis | en_US |
dc.subject | Antigen Expression | en_US |
dc.subject | Breast Carcinoma | en_US |
dc.subject | Cancer Surgery | en_US |
dc.subject | Carcinoma Cell | en_US |
dc.subject | Cell Proliferation | en_US |
dc.subject | Gene Overexpression | en_US |
dc.subject | Growth Stimulation | en_US |
dc.subject | Human | en_US |
dc.subject | Letter | en_US |
dc.subject | Metastasis | en_US |
dc.subject | Physiology | en_US |
dc.subject | Priority Journal | en_US |
dc.subject | Tumor | en_US |
dc.subject | Tumor growth | en_US |
dc.subject | Wound | en_US |
dc.subject | Breast tumor | en_US |
dc.subject | Cell division | en_US |
dc.subject | Female | en_US |
dc.subject | Gene expression regulation | en_US |
dc.subject | Genetics | en_US |
dc.subject | Note | en_US |
dc.subject | Pathophysiology | en_US |
dc.subject | Proto oncogene | en_US |
dc.subject | Structure activity relation | en_US |
dc.subject | Carcinoma in situ | en_US |
dc.subject | Drug antagonism | en_US |
dc.subject | Neovascularization (pathology) | en_US |
dc.subject | Breast neoplasms | en_US |
dc.subject | Cell division | en_US |
dc.subject | Female | en_US |
dc.subject | Gene expression regulation | en_US |
dc.subject | Neoplastic | en_US |
dc.subject | Genes | en_US |
dc.subject | Erbb-2 | en_US |
dc.subject | Humans | en_US |
dc.subject | Matrix metalloproteinase 1 | en_US |
dc.subject | Receptor | en_US |
dc.subject | Erbb-2 | en_US |
dc.subject | Structure-activity relationship | en_US |
dc.subject | Antibodies | en_US |
dc.subject | Monoclonal | en_US |
dc.subject | Breast neoplasms | en_US |
dc.subject | Carcinoma in situ | en_US |
dc.subject | Neovascularization | en_US |
dc.subject | Pathologic | en_US |
dc.subject | Vascular endothelial growth factor A | en_US |
dc.title | HER2 and proliferation of wound-induced breast carcinoma | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 10.1016-S0140-6736(03)14708-3.pdf
- Size:
- 53.31 KB
- Format:
- Adobe Portable Document Format
- Description:
- Full printable version